“We are proud to help redefine CML treatment once again with Scemblix, as we continue to deliver on our 20+ year commitment to innovation and support in CML,” said Victor Bulto, President US, Novartis ...

The internet was flooded with iPad mini 7 reviews this week after Apple's quiet announcement of the mini tablet on October 15. Given it's been three years since we last saw Apple launch an 8.3 ...

The event also saw the debut of the Pad 3 Pro tablet and Enco X3 TWS earphones. The tablet is actually the OnePlus Pad 2 under a new name and available in two new colors, while the Enco X3 are ...

The Chinese tech giant’s new tablets are expected to launch with a premium design. Rumors have hinted that the Xiaomi Pad 7 and Xiaomi Pad 7 Pro feature an all-metal body, which isn’t ...

Google’s first Pixel Tablet is unique in a lot of ways, but it’s ultimately not a product that fits everyone’s needs. But, with an ongoing sale, the Pixel Tablet is an absolute steal.

Though it keeps the portrait-oriented front camera and is incompatible with Apple Pencil 2, this tablet’s strengths outweigh its flaws. The iPad mini 7 delivers the full iPad experience ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (EMA) recommended granting approval to the breast cancer drug Kisqali ...

It comes as oral tablets and orally disintegrating tablets and is typically taken two to three times per day. The dosage may vary. Clonazepam tablets are approved by the Food and Drug ...

With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies that have failed in their legal challenges to the Inflation Reduction Act. A ...

The Great Indian Festival's exclusive Diwali sale prices are live, offering up to 80% off on tablets from top brands like Apple, Samsung, One Plus and more. The Great Indian Festival has started ...

Children’s poor educational test scores are a major cause for concern across the world. Outcomes plummeted nearly everywhere during the COVID-19 pandemic — but even before then, standardized ...

If approved, Kisqali could nearly double the number of patients eligible for CDK4/6 inhibitor adjuvant therapy,” said Patrick Horber M.D., President, International, Novartis. “Together with the recent ...